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Cellular senescence is a response to damage that involves inflammation and extracellular matrix remodeling
and that resolves with the phagocytic elimination of the senescent cells. Demaria et al. (2014) in this issue of
Developmental Cell demonstrate that cellular senescence plays an active and positive role during tissue
regeneration.The concept of cellular senescence dates
back more than 50 years, much earlier
than the concept of apoptosis. Since its
initial description, our understanding of
cellular senescence has evolved dramati-
cally. Formany years, cellular senescence
was conceptualized as a poorly defined
cell-cycle arrest akin to organismal aging.
Today, cellular senescence can be con-
sidered to be a variant of the apoptotic
cellular suicide paradigm and, more
specifically, an ‘‘assisted cellular sui-
cide.’’ The current script of cellular senes-
cence (reviewed in Mun˜oz-Espı´n and
Serrano, 2014) can be summarized as fol-
lows. In response to cellular damage,
stress, oncogenic signaling, or even dur-
ing embryonic development, cells can
stably disable their proliferation machin-
ery through the action, in various combi-
nations, of tumor suppressors, including
p16INK4a, retinoblastoma, p53, p21CIP1,
and others. Senescent cells generally
present two characteristic features: an
expansion of the lysosomal compart-
ment, which results in increased lyso-
somal b-galactosidase activity (known as
senescence-associated b-galactosidase,
or SAbG), and the formation of distinctive
heterochromatic structures (known as
senescence-associated heterochromatin
foci, or SAHFs). At a functional level,
senescent cells release a complex
mixture of extracellular matrix proteases,
growth factors, chemokines, and cyto-
kines (collectively known as senescence-
associated secretory phenotype, or
SASP), which has profound effects on
the tissue microenvironment. In partic-
ular, the SASP may activate the motility
and proliferation of surrounding cells
and may recruit immune and phagocytic
cells, including macrophages. The latter
are the final ‘‘assistants’’ for the demise
of senescent cells. Therefore, in contrastto the rather individual and silent pro-
cess of apoptosis (cellular suicide),
senescence (assisted cellular suicide)
involves a cast of characters with com-
plex roles.
Still, the ultimate logic of senescence
has remained speculative. If the purpose
of senescence is the elimination of
cells, then why not use the direct and
fast route of apoptosis? An emerging
concept, based on the aforementioned
events, is that senescent cells, before
dying, make a late service to their host
tissue by eliciting a tissue remodeling
process that includes their own elimina-
tion. A particularly striking example of
the role of senescence in tissue remodel-
ing has been the recent demonstration
that senescence participates in multiple
developmental processes in vertebrates
(Mun˜oz-Espı´n et al., 2013; Storer et al.,
2013). A new paper from Demaria et al.
(2014) now provides further evidence for
a physiological role of senescence in
tissue remodeling, and more specifically
during wound healing.
Genetically engineered mice with in-
creased or decreased activity of genes
critical for the induction of senescence
often present abnormal responses to
tissue damage. For example, mice defi-
cient in p53 have an accelerated wound
healing (Nakade et al., 2004), while mice
with excessive p53 activity have a
delayed wound healing (Gannon et al.,
2011). While these observations are
certainly of great interest, the experi-
mental models used cannot distinguish
the contribution of p53-dependent senes-
cence from the many other processes
regulated by p53, including prolifera-
tion, apoptosis, differentiation, immune
responses, or angiogenesis.
To address the physiological role of
senescence, it is necessary to developDevelopmental Cell 31, Dclever strategies that allow the selective
elimination of senescent cells in vivo.
Two groups have been able to achieve
this by employing independent but similar
strategies (Baker et al., 2011; Demaria
et al., 2014). The groups of Jan van
Deursen and Judith Campisi have gener-
ated transgenic mice in which the pro-
moter of p16INK4a directs the expression
of pro-apoptotic proteins that can be tur-
ned on with a chemical switch. Because
senescent cells are known to express
high levels of p16INK4a, it is reasonable to
assume that the targeted cells are senes-
cent. Therefore, in vivo administration of
the chemical switch converts senescence
into apoptosis.
The group of van Deursen has previ-
ously used their ‘‘inducible senescence-
to-apoptosis’’ system in a progericmouse
model (bearing homozygous hypomor-
phic alleles of the BubR1 gene). These
progeric mice suffer widespread and
continuous cellular damage that rapidly
builds up to produce accelerated aging
and the accumulation of senescent
cells. By inducing the senescence-to-
apoptosis switch, the overload of senes-
cent cellswasdecreased, and, remarkably,
some advanced progeric pathologies,
such as cataracts or muscle atrophy,
were partially reverted (Baker et al., 2011).
From this and other studies, it can be
concluded that in aged organisms (or in or-
ganisms undergoing severe levels of dam-
age), senescent cells are not properly
cleared by phagocytic cells, accumulate
and eventually aggravate tissue dysfunc-
tion. Conceivably, aged or chronically
damaged tissues are not amenable to
senescence-induced tissue remodeling,
probably reflecting a combination of fac-
tors, suchas amore static extracellularma-
trix, inefficient recruitment of phagocytic
cells, impaired clearance of senescenctecember 22, 2014 ª2014 Elsevier Inc. 671
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Previewscells, or defective regenerative capacity of
neighbor progenitor cells.
In the current issue of Developmental
Cell, the Campisi group uses their ‘‘induc-
ible senescence-to-apoptosis’’ mice to
study the role of senescence during skin
wound healing (Demaria et al., 2014).
It is important to emphasize that, aside
from harboring the senescence-to-
apoptosis transgene, the mice employed
are young and healthy, with no additional
genetic defects that may introduce
confounding effects. The investigators
observed that during wound healing there
is a transient burst of senescent cells
that vanishes with wound closure. Impor-
tantly, conversion of senescence into
apoptosis blunted the peak of senes-
cence and this translated into a signifi-
cantly delayed wound healing. These
observations constitute the first direct
demonstration, in a truly normal in vivo
context, that cellular senescence con-
tributes to tissue remodeling. Like the
phoenix of ancient Greek mythology, it
can then be said that skin wounds regen-
erate from the ashes of senescence.
When the healing process was care-
fully examined histologically, the inves-
tigators found that, in the absence
of senescence, wounds accumulated
excessive fibrotic tissue (which macro-
scopically translates to a more pro-
nounced scar) (Demaria et al., 2014).
This is in line with previous studies, which
also concluded that cellular senescence
is important for limiting fibrosis during
tissue repair, as it has been shown in
skin (Jun and Lau, 2010), liver (Krizhanov-
sky et al., 2008), and several other fibrotic
pathologies (Mun˜oz-Espı´n and Serrano,
2014).672 Developmental Cell 31, December 22, 20A very useful feature of the mice devel-
oped by Campisi and coworkers is that
the p16INK4a-regulated transgene also
directs the expression of a fluorescent
protein (Demaria et al., 2014). Using this
tool, the investigators were able to isolate
and characterize the cells that undergo
senescence during skin wound healing.
Two important findings emerged from
these analyses: first, the cells that un-
dergo senescence are fibroblasts and
endothelial cells, but not keratinocytes;
and, second, the growth factor PDGF-A
is characteristically expressed in senes-
cent fibroblasts and endothelial cells
during wound healing. The latter finding
is of relevance because the related
PDGF-B factor is clinically approved for
the treatment of skin ulcers (Jeffcoate
and Game, 2014). In line with this, the
abnormal wound healing observed in the
absence of senescence was fully rescued
by topical administration of recombinant
PDGF-A to the wounds (Demaria et al.,
2014).
Studies like this are changing our
understanding of cellular senescence,
placing this response at the center of
tissue regeneration. The full benefits
of senescence are achieved when the
process includes the clearance of the se-
nescent cells, thereby restoring the pre-
damage status of the tissue. However, in
chronic pathological situations, including
aging, senescent cells are not efficiently
clearedandcontinuousdamageeventually
results in the accumulation of senescent
cells, which can further aggravate tissue
dysfunction. This double-edged sword of
senescence is reminiscent of inflamma-
tion, which is beneficial when it is transient
and efficiently resolved but pathological14 ª2014 Elsevier Inc.when chronic and unresolved. These
nuances and complexities of senescence
demand further investigations into the ther-
apeutic potential of enhancing or blocking
senescence, depending on the context.
The current report is inspiration for such
investigation, as it integrates the role of
senescence in regeneration together with
the therapeutic benefits of PDGF in wound
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